US Stock MarketDetailed Quotes

VRCA Verrica Pharmaceuticals

Watchlist
  • 0.700
  • -0.050-6.71%
Close Jan 8 16:00 ET
  • 0.700
  • 0.0000.00%
Post 20:01 ET
63.37MMarket Cap-0.38P/E (TTM)

Verrica Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
-161.06%-1.78M
2,744.51%5.18M
10,240.54%3.83M
-43.27%5.12M
2,823.53%1.99M
-64.94%2.92M
-14.95%182K
-91.42%37K
-24.73%9.03M
68K
Operating revenue
-161.06%-1.78M
2,744.51%5.18M
10,240.54%3.83M
-43.27%5.12M
2,823.53%1.99M
-64.94%2.92M
-14.95%182K
-91.42%37K
-24.73%9.03M
--68K
Cost of revenue
61.11%435K
298.53%542K
1,573.53%1.14M
2.90%746K
338.71%272K
62.65%270K
-37.90%136K
-75.54%68K
725K
62K
Gross profit
-183.72%-2.22M
9,976.09%4.64M
8,770.97%2.69M
-47.30%4.38M
28,500.00%1.72M
-67.53%2.65M
1,020.00%46K
-120.26%-31K
-30.78%8.31M
6K
Operating expense
-30.40%18.49M
70.13%19.84M
201.60%21.29M
128.36%67.6M
258.94%22.32M
296.18%26.56M
27.93%11.66M
-6.68%7.06M
-31.01%29.6M
-26.60%6.22M
Selling and administrative expenses
-19.80%16.08M
178.29%16.52M
278.31%16.34M
171.79%47.31M
432.93%17M
410.93%20.05M
14.77%5.94M
-15.61%4.32M
-35.49%17.41M
-37.63%3.19M
Research and development costs
-63.06%2.41M
-42.03%3.32M
80.65%4.95M
66.38%20.3M
75.69%5.32M
134.17%6.51M
45.19%5.73M
12.02%2.74M
-23.42%12.2M
-9.80%3.03M
Operating profit
13.43%-20.7M
-30.91%-15.21M
-162.36%-18.6M
-196.87%-63.22M
-231.65%-20.6M
-1,751.73%-23.92M
-27.35%-11.62M
4.33%-7.09M
31.10%-21.3M
26.67%-6.21M
Net non-operating interest income expense
-158.08%-2.16M
-415.50%-1.98M
-444.20%-1.72M
27.95%-1.22M
-629.02%-1.51M
-1,346.27%-835K
159.85%626K
147.17%500K
59.35%-1.7M
126.73%286K
Non-operating interest income
-73.11%221K
-37.22%393K
19.60%598K
475.63%2.74M
176.92%792K
455.41%822K
3,030.00%626K
2,172.73%500K
286.99%476K
959.26%286K
Non-operating interest expense
43.39%2.38M
--2.37M
--2.32M
82.41%3.96M
--2.31M
1,945.68%1.66M
--0
--0
-49.43%2.17M
--0
Other net income (expense)
98.00%-1K
-5K
-11K
-70.64%-2.55M
-35,642.86%-2.5M
96.51%-50K
-1.5M
-7K
Special income (charges)
----
----
----
-76.55%-2.54M
----
----
----
----
---1.44M
--0
-Less:Other special charges
----
----
----
----
----
----
----
----
--1.44M
--0
-Gain on sale of property,plant,equipment
----
----
----
---2.54M
----
----
----
----
--0
----
Other non- operating income (expenses)
98.00%-1K
---5K
---11K
75.86%-14K
600.00%35K
-1,100.00%-50K
----
----
---58K
---7K
Income before tax
7.83%-22.86M
-56.38%-17.19M
-208.56%-20.33M
-173.59%-67M
-314.94%-24.61M
-29,981.93%-24.8M
-8.08%-10.99M
22.21%-6.59M
30.20%-24.49M
37.82%-5.93M
Income tax
Net income
7.83%-22.86M
-56.38%-17.19M
-208.56%-20.33M
-173.59%-67M
-314.94%-24.61M
-29,981.93%-24.8M
-8.08%-10.99M
22.21%-6.59M
30.20%-24.49M
37.82%-5.93M
Net income continuous Operations
7.83%-22.86M
-56.38%-17.19M
-208.56%-20.33M
-173.59%-67M
-314.94%-24.61M
-29,981.93%-24.8M
-8.08%-10.99M
22.21%-6.59M
30.20%-24.49M
37.82%-5.93M
Minority interest income
Net income attributable to the parent company
7.83%-22.86M
-56.38%-17.19M
-208.56%-20.33M
-173.59%-67M
-314.94%-24.61M
-29,981.93%-24.8M
-8.08%-10.99M
22.21%-6.59M
30.20%-24.49M
37.82%-5.93M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
7.83%-22.86M
-56.38%-17.19M
-208.56%-20.33M
-173.59%-67M
-314.94%-24.61M
-29,981.93%-24.8M
-8.08%-10.99M
22.21%-6.59M
30.20%-24.49M
37.82%-5.93M
Basic earnings per share
9.26%-0.49
-54.17%-0.37
-193.33%-0.44
-105.56%-1.48
-285.71%-0.54
-26,326.32%-0.54
35.14%-0.24
51.61%-0.15
44.62%-0.72
60.00%-0.14
Diluted earnings per share
9.26%-0.49
-54.17%-0.37
-193.33%-0.44
-105.56%-1.48
-285.71%-0.54
-26,339.07%-0.54
35.14%-0.24
51.61%-0.15
44.62%-0.72
60.00%-0.14
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024 (Q2)Jun 30, 2024 (Q1)Mar 31, 2024 (FY)Dec 31, 2023 (Q4)Dec 31, 2023 (Q3)Sep 30, 2023 (Q2)Jun 30, 2023 (Q1)Mar 31, 2023 (FY)Dec 31, 2022 (Q4)Dec 31, 2022
Total revenue -161.06%-1.78M 2,744.51%5.18M 10,240.54%3.83M -43.27%5.12M 2,823.53%1.99M -64.94%2.92M -14.95%182K -91.42%37K -24.73%9.03M 68K
Operating revenue -161.06%-1.78M 2,744.51%5.18M 10,240.54%3.83M -43.27%5.12M 2,823.53%1.99M -64.94%2.92M -14.95%182K -91.42%37K -24.73%9.03M --68K
Cost of revenue 61.11%435K 298.53%542K 1,573.53%1.14M 2.90%746K 338.71%272K 62.65%270K -37.90%136K -75.54%68K 725K 62K
Gross profit -183.72%-2.22M 9,976.09%4.64M 8,770.97%2.69M -47.30%4.38M 28,500.00%1.72M -67.53%2.65M 1,020.00%46K -120.26%-31K -30.78%8.31M 6K
Operating expense -30.40%18.49M 70.13%19.84M 201.60%21.29M 128.36%67.6M 258.94%22.32M 296.18%26.56M 27.93%11.66M -6.68%7.06M -31.01%29.6M -26.60%6.22M
Selling and administrative expenses -19.80%16.08M 178.29%16.52M 278.31%16.34M 171.79%47.31M 432.93%17M 410.93%20.05M 14.77%5.94M -15.61%4.32M -35.49%17.41M -37.63%3.19M
Research and development costs -63.06%2.41M -42.03%3.32M 80.65%4.95M 66.38%20.3M 75.69%5.32M 134.17%6.51M 45.19%5.73M 12.02%2.74M -23.42%12.2M -9.80%3.03M
Operating profit 13.43%-20.7M -30.91%-15.21M -162.36%-18.6M -196.87%-63.22M -231.65%-20.6M -1,751.73%-23.92M -27.35%-11.62M 4.33%-7.09M 31.10%-21.3M 26.67%-6.21M
Net non-operating interest income expense -158.08%-2.16M -415.50%-1.98M -444.20%-1.72M 27.95%-1.22M -629.02%-1.51M -1,346.27%-835K 159.85%626K 147.17%500K 59.35%-1.7M 126.73%286K
Non-operating interest income -73.11%221K -37.22%393K 19.60%598K 475.63%2.74M 176.92%792K 455.41%822K 3,030.00%626K 2,172.73%500K 286.99%476K 959.26%286K
Non-operating interest expense 43.39%2.38M --2.37M --2.32M 82.41%3.96M --2.31M 1,945.68%1.66M --0 --0 -49.43%2.17M --0
Other net income (expense) 98.00%-1K -5K -11K -70.64%-2.55M -35,642.86%-2.5M 96.51%-50K -1.5M -7K
Special income (charges) ---- ---- ---- -76.55%-2.54M ---- ---- ---- ---- ---1.44M --0
-Less:Other special charges ---- ---- ---- ---- ---- ---- ---- ---- --1.44M --0
-Gain on sale of property,plant,equipment ---- ---- ---- ---2.54M ---- ---- ---- ---- --0 ----
Other non- operating income (expenses) 98.00%-1K ---5K ---11K 75.86%-14K 600.00%35K -1,100.00%-50K ---- ---- ---58K ---7K
Income before tax 7.83%-22.86M -56.38%-17.19M -208.56%-20.33M -173.59%-67M -314.94%-24.61M -29,981.93%-24.8M -8.08%-10.99M 22.21%-6.59M 30.20%-24.49M 37.82%-5.93M
Income tax
Net income 7.83%-22.86M -56.38%-17.19M -208.56%-20.33M -173.59%-67M -314.94%-24.61M -29,981.93%-24.8M -8.08%-10.99M 22.21%-6.59M 30.20%-24.49M 37.82%-5.93M
Net income continuous Operations 7.83%-22.86M -56.38%-17.19M -208.56%-20.33M -173.59%-67M -314.94%-24.61M -29,981.93%-24.8M -8.08%-10.99M 22.21%-6.59M 30.20%-24.49M 37.82%-5.93M
Minority interest income
Net income attributable to the parent company 7.83%-22.86M -56.38%-17.19M -208.56%-20.33M -173.59%-67M -314.94%-24.61M -29,981.93%-24.8M -8.08%-10.99M 22.21%-6.59M 30.20%-24.49M 37.82%-5.93M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 7.83%-22.86M -56.38%-17.19M -208.56%-20.33M -173.59%-67M -314.94%-24.61M -29,981.93%-24.8M -8.08%-10.99M 22.21%-6.59M 30.20%-24.49M 37.82%-5.93M
Basic earnings per share 9.26%-0.49 -54.17%-0.37 -193.33%-0.44 -105.56%-1.48 -285.71%-0.54 -26,326.32%-0.54 35.14%-0.24 51.61%-0.15 44.62%-0.72 60.00%-0.14
Diluted earnings per share 9.26%-0.49 -54.17%-0.37 -193.33%-0.44 -105.56%-1.48 -285.71%-0.54 -26,339.07%-0.54 35.14%-0.24 51.61%-0.15 44.62%-0.72 60.00%-0.14
Dividend per share
Currency Unit USD USD USD USD USD USD USD USD USD USD
Accounting Standards US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP
Audit Opinions -- -- -- Unqualified Opinion -- -- -- -- Unqualified Opinion with Explanatory Notes --
Heat List
US
Overall
Symbol
Price
% Chg

No Data